Tag: FDA Section 505A

Pediatric Exclusivity: How the FDA Extends Market Protection for Drugs

By Joe Barnett    On 28 Nov, 2025    Comments (14)

blog-post-image

Pediatric exclusivity gives drugmakers six extra months of market protection after completing FDA-requested studies in children. It doesn't extend patents but blocks generic approval, even after patent expiration, ensuring safer pediatric dosing.

View More

Categories

Recent Post

recent-post-image How to Ask About Generics and Authorized Generics to Save Money on Prescription Drugs
recent-post-image Ketotifen vs. Other Allergy Treatments: Full Comparison Guide
recent-post-image Buy Generic Prilosec (Omeprazole) Online Cheap in the UK: Safe, Smart 2025 Guide
recent-post-image How Stress Triggers Hypertension and Proven Ways to Manage It
recent-post-image Mormon Tea Supplement: Proven Benefits and How It Works

Menu

© 2026. All rights reserved.